Nuvectra to Present at the Wedbush PacGrow Healthcare Conference
July 28 2017 - 8:30AM
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical
device company, announced today that Scott Drees, Chief Executive
Officer, and Walter Berger, Chief Operating Officer & Chief
Financial Officer, are scheduled to present at the Wedbush PacGrow
Healthcare Conference in New York, NY. Management will also be
available for one-on-one meetings at the conference.
Event:
Wedbush PacGrow Healthcare
ConferenceFormat: Presentation
and One-on-One MeetingsDate:
Wednesday, August 16,
2017Time: 1:20 pm
ET
A webcast of the Company’s presentation will be
available on the investor relations section of Nuvectra’s website
at www.nuvectramed.com. A webcast replay of the chat will be
available for 90 days.
About Nuvectra Corporation
NuvectraTM is a neurostimulation company committed to helping
physicians improve the lives of people with chronic neurological
conditions. The Algovita® Spinal Cord Stimulation (SCS) System is
our first commercial offering and is CE marked and FDA approved for
the treatment of chronic intractable pain of the trunk and/or
limbs. Our innovative technology platform also has capabilities
under development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. In addition, our NeuroNexus subsidiary designs,
manufactures and markets leading-edge neural-interface technologies
for the neuroscience clinical research market. Visit the Nuvectra
website at www.nuvectramed.com.
Company Contacts:
Nuvectra Corporation
Walter Berger, COO & CFO
(214) 474-3102
wberger@nuvectramed.com
Jennifer Armstrong, Media Relations
(214) 474-3110
jarmstrong@nuvectramed.com
Investor Contacts:
The Ruth Group
Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com
Brian Johnston
(646) 536-7028
bjohnston@theruthgroup.com
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From May 2024 to Jun 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Jun 2023 to Jun 2024